Industry Connect with CSL
UQ researchers are cordially invited to attend an information session or tune into scheduled webinars to hear Dr Marthe D’Ombrain of CSL launch their
2020 Research Acceleration Initiative.
CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and UQ, and other Australian research organisations.
The initiative focuses on early stage projects that have potential to impact therapies for patients in CSL’s therapeutic areas, focus areas and modalities of interest (see below)
Successful applicants will receive up to $250,000 per year for up to 2 years (max $500,000 funding) to accelerate translation of their research.
Therapeutic areas
Immunology
Neurology
Haematology
Thrombosis
Transplant
Respiratory
Cardiovascular/metabolic
Focus areas
Novel drug targets
Novel therapeutic candidates
Novel strategies for treating disease
Modalities
Antibodies
Protein therapeutics
Gene therapies
Cell therapies
Small molecules are not of interest
Event details
Time
1:00pm - 2:30pm
Date
Tuesday, 18 February 2020
Venue
Room 275, Level 2
Global Change Institute (#20)
Staff House Road
St Lucia Campus
RSVP
rsvp@uniquest.com.au
by Friday, 14 February 2020
Webinar details
Time
12:00pm - 1:00pm
11:30am - 12:30pm
Date
Monday, 17 February 2020
Thursday, 20 February 2020
CSL Research Acceleration Initiative
Scientific Call for Applications
APPLICATIONS CLOSE 13 MARCH 2020
- Please contact UniQuest or email csl@uniquest.com.au to request an application form
- Forward completed applications to csl@uniquest.com.au
by Friday, 13 March 2020